Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? – A retrospective study

4Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Equine glandular gastric disease (EGGD) is a common condition of the horse. Misoprostol is reported to be superior to oral omeprazole and sucralfate for treatment. Long-acting intramuscular injectable omeprazole (LAIOMEP) is a novel treatment shown to be effective in a small population. Objectives: This study aimed to determine LAIOMEP efficacy compared to misoprostol and oral omeprazole and identify characteristics that predict treatment outcome. Methods: All horses that underwent gastroscopy between 2012 and 2019 were reviewed. Lesions were characterised by 4 blinded observers, all of whom are diplomates in equine internal medicine, using established descriptors from the ECEIM consensus statement and subjective severity. Treatment outcome was ranked as worsened, improved or healed. Consensus lesion type, lesion severity and treatment choice were compared to outcome and data screened using univariate analysis (chi-squared) to determine whether each predicted outcome. Lesion types where univariate analysis predicted a trend (p<0.2) were included in a multiple-regression analysis to identify predictors of outcome irrespective of treatment. Results: Only severity significantly predicted final outcome (p = 0.025) with severe lesions being more likely to improve. Treatment choice did not significantly predict outcome. Overall healing rate was 29% (24 horses), and 43% (44 horses) improved. Treatment healing rates were 23% (10), 12% (7) and 27% (7) for LAIOMEP, misoprostol and oral omeprazole, respectively, with improvement in 69% (14), 76% (21) and 61% (9). 64% of the latter group received sucralfate. Worsening occurred in 7% (6). Treatment length varied with a median of 4 weeks (range 4–20 weeks). Conclusions: This study showed poorer therapy outcome compared to previous studies. The only initial lesion descriptor to predict outcome was severity and treatment choice did not affect outcome.

References Powered by Scopus

The Delphi technique: Myths and realities

1765Citations
N/AReaders
Get full text

European College of Equine Internal Medicine Consensus Statement-Equine Gastric Ulcer Syndrome in Adult Horses

238Citations
N/AReaders
Get full text

A comparison of three doses of omeprazole in the treatment of equine gastric ulcer syndrome: A blinded, randomised, dose-response clinical trial

68Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Review of equine glandular gastric disease

1Citations
N/AReaders
Get full text

Low therapeutic success rates with both high-dose therapy with omeprazole granules (Equizol©) and combination therapy with omeprazole paste (Gastrogard®) and sucralfate (Sucrabest®) in horses with Equine Glandular Gastric Disease (EGGD)

1Citations
N/AReaders
Get full text

Towards the Identification of New Biomarkers in Saliva and Serum for Treatment Monitoring of Equine Gastric Ulcer Syndrome: A Liquid Proteomic Approach

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Pratt, S. L., Bowen, M., Hallowell, G. H., Shipman, E., Bailey, J., & Redpath, A. (2023). Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? – A retrospective study. Veterinary Medicine and Science, 9(1), 150–157. https://doi.org/10.1002/vms3.1034

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

50%

Researcher 3

38%

Professor / Associate Prof. 1

13%

Readers' Discipline

Tooltip

Veterinary Science and Veterinary Medic... 7

58%

Medicine and Dentistry 2

17%

Pharmacology, Toxicology and Pharmaceut... 2

17%

Agricultural and Biological Sciences 1

8%

Save time finding and organizing research with Mendeley

Sign up for free